Used as a key intermediate in the synthesis of certain antibacterial agents, particularly in the development of oxazolidinone-class antibiotics. Its structure enables effective binding to bacterial ribosomes, inhibiting protein synthesis in resistant strains such as MRSA and VRE. Due to its functional groups and stereochemistry, it enhances the pharmacokinetic properties of the final drug, improving bioavailability and tissue penetration. Commonly employed in pharmaceutical research for optimizing antimicrobial efficacy and reducing off-target effects.